Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara L Parsons

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Mutation Research. Reviews in Mutation Research|August 18, 2018
Multiclonal tumor origin: Evidence and implicationsBarbara L Parsons
Mutation Research. Reviews in Mutation Research|October 6, 2024
Clonal expansion of cancer driver gene mutants investigated using advanced sequencing technologiesBarbara L Parsons
Mutation Research|July 11, 2008
Many different tumor types have polyclonal tumor origin: evidence and implicationsBarbara L Parsons
Proceedings of the National Academy of Sciences of the United States of America|January 18, 2011
Monoclonal tumor origin is an underlying misconception of the RESIC approachBarbara L Parsons
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2003
MED1: a central molecule for maintenance of genome integrity and response to DNA damageBarbara L Parsons
Biomarkers in Medicine|May 19, 2010
K-RAS mutation in the screening, prognosis and treatment of cancerBarbara L Parsons, Fanxue Meng
Mutation Research. Reviews in Mutation Research|March 21, 2020
Passing of the pen: Editorship of Mutation Research - Reviews in Mutation ResearchBarbara L Parsons, Catherine B Klein
Discovery Medicine|May 3, 2013
Personalized cancer treatment and the myth of KRAS wild-type colon tumorsBarbara L Parsons, Meagan B Myers
Personalized Medicine|November 22, 2016
<i>KRAS</i> mutant tumor subpopulations can subvert durable responses to personalized cancer treatmentsBarbara L Parsons, Meagan B Myers
Mutation Research|May 30, 2002
Detection of rare K-ras codon 12 mutations using allele-specific competitive blocker PCRPage B McKinzie, Barbara L Parsons
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Mutation Research. Reviews in Mutation Research|August 18, 2018
Multiclonal tumor origin: Evidence and implicationsBarbara L Parsons
Mutation Research. Reviews in Mutation Research|October 6, 2024
Clonal expansion of cancer driver gene mutants investigated using advanced sequencing technologiesBarbara L Parsons
Mutation Research|July 11, 2008
Many different tumor types have polyclonal tumor origin: evidence and implicationsBarbara L Parsons
Proceedings of the National Academy of Sciences of the United States of America|January 18, 2011
Monoclonal tumor origin is an underlying misconception of the RESIC approachBarbara L Parsons
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2003
MED1: a central molecule for maintenance of genome integrity and response to DNA damageBarbara L Parsons
Biomarkers in Medicine|May 19, 2010
K-RAS mutation in the screening, prognosis and treatment of cancerBarbara L Parsons, Fanxue Meng
Mutation Research. Reviews in Mutation Research|March 21, 2020
Passing of the pen: Editorship of Mutation Research - Reviews in Mutation ResearchBarbara L Parsons, Catherine B Klein
Discovery Medicine|May 3, 2013
Personalized cancer treatment and the myth of KRAS wild-type colon tumorsBarbara L Parsons, Meagan B Myers
Personalized Medicine|November 22, 2016
<i>KRAS</i> mutant tumor subpopulations can subvert durable responses to personalized cancer treatmentsBarbara L Parsons, Meagan B Myers
Mutation Research|May 30, 2002
Detection of rare K-ras codon 12 mutations using allele-specific competitive blocker PCRPage B McKinzie, Barbara L Parsons
Pageof 7